I received a score of great nominations for your Stem Cell Person of the Year 2016 Award and also have briefly described the twenty nominees below. The purpose of the award is to honor the top positive originate cell leader who specifically thinks outside the box and requires risks.
Soon I will start an on the web vote where you can vote once per day for your favorite nominee(s) for Stem Cell Person of the Year. The very best half or so of nominees getting the most votes would be the finalists from which I will choose the final winner, who gets the $2, 000 prize and international recognition as being a global leader in the stem cell and regenerative medication field.
Past winners of the Stem Cellular Person of the Year Award include the following:
- Top stem cell scientist Jeanne Loring in 2015.
- Pioneering eyesight and pluripotent stem cell clinical researcher, Masayo Takahashi in 2014.
- Neural stem cell scientist and very effective Italian politician Elena Cattaneo in 2013.
- Stem cell patient advocate Roman Reed in 2012.
Here are the particular 2016 nominees in alphabetical order frist by name with some description of who they are as well as a bit of the words from the person(s) who nominated them in some instances. Where I could find a link to websites describing their achievements, I have provided those.
Amy Bets, Professor at Harvard. She has a long track record of cutting edge research on come cells including recently very provocative work on the function of stem cells in human aging and methods to reversing aging.
Arnold Caplan , Professor at Case Western Reserve . He is often considered the “ father” of the mesenchymal stem/stromal cell (medicinal signaling cell) field and has accomplished important research on MSCs over many years.
Connie Eaves, Distinguished Investigator from Terry Fox Laboratory at UBC. She has an amazing track record of innovative research on stem cells including each normal and cancer stem cells and a reputation being a fantastic mentor and leader in the field more generally. “ Brilliant scientist with unmatched piercing view of science”.
Hiroshi Nagashima, Professor at Meiji University, Tokyo . “ A genuine translational scientist (with a wicked sense of humor! )” He or she works in part on cloning technology and could revolutionize body organ transplantation approaches leading to huge impact.
Jim Gass. Jim is a patient that suffered a stroke and then sought stem cell remedies to try to reverse some of the damage. Somewhere along the lines, a number of the unproven stem cell therapies he received triggered him to develop a spinal tumor. He previously the courage to go public with his tale and describe his experiences, potentially risking litigation. “ A gutsy man who has prevented others from obtaining injured. ”
John Pimanda, Associate Professor of Medicine and Stem Cell The field of biology, UNSW Australia. He researches transcriptional legislation of adult stem cells and now the usage of fat stem cells for spine injury .
Judy Roberson. She is a tireless Huntington’ s Disease (HD) advocate, always working to make a positive difference. “ She actually is a straight shooter who will tell you what she believes and work to make it a reality. ”
Jun Takahashi. He is a Professor at CiRA and pluripotent come cell biology researcher. Jun has done pioneering IPSC research and is working to start a very exciting Parkinson’ ersus Disease clinical trial using IPSC in Japan.
Margaret Goodell, Professor at Baylor College of Medicine . She actually is an internationally respected scholar in the stem cell industry. She conducts cool, innovative research on transcriptional plus epigenetic regulation of hematopoietic stem cells and how this particular goes awry in leukemias.
Paul West . Often mentioned as one of the founders of the regenerative medicine field, he is the leader of BioTime and is a thought leader in the field. “ Mike knows all about taking risks in regenerative medication leading to big, positive leaps forward. ”
Nissim Benvenisty , Professor of Genetics on the Hebrew University of Jerusalem. He is a super-prolific, long-time stem cell researcher. His latest work this year has been on revolutionary production of haploid ES cells.
Oliver Brustle, Professor and Director of the Institute associated with Reconstructive Neurobiology and Professor of Reconstructive Neurobiology in the University of Bonn Medical Center. He conducts innovative nerve organs stem cell research and is a globally respected come cell leader.
Randy Mills , President and CEO of CIRM . He has been a leader in stem cell biotech for a long time and has shaken things up at the helm of CIRM using a much more translational emphasis. “ Randy has CIRM on the right track to meaningful clinical outcomes in a way that I cannot imagine an additional leader could have achieved. The outcome will change the world. ”
Richard Ambinder, Johns Hopkins Hospital. Professor Ambinder has been doing pioneering work in the area of stem cells and infections, including HIV, as well as stem cells for patients along with hematopoietic malignancies. A scientist with a prodigious publication report of high-impact papers.
Robert Lanza . He has been a regenerative medication leader for, what, decades? Long time technological leader behind ACT and then its new incarnation because Ocata, which was purchased by Astellas and he leads worldwide regenerative medicine at Astellas. ” We expect something totally new and big from Bob at every turn”.
Sally Temple, Scientific Director, Co-Founder, and Theory Investigator at the Neural Stem Cell Institute. She is also the President of ISSCR. Scholar plus innovative researcher in the stem cell field with a concentrate on stem cells in the brain. Past MacArthur Fellow. “ One of the brightest developmental biologists in the world and a natural innovator. ”
Sheng Ding , Senior Investigator, Gladstone Institute associated with Cardiovascular Disease. Dr . Ding has done some of the most creative plus impactful research in the stem cell field to date, plus continues to crank out new discoveries in particular related to chemical substance reprogramming. He also has co-founded a number of exciting biotechs which includes Fate Therapeutics. “ He has been a positive head in the stem cell field, and his outside-of-the-box thinking provides greatly enhanced our collective efforts to advance the field. ”
Shoukhrat Mitalipov, Professor at ONPRC and OHSU. Shoukhrat is a top researcher in the stem and germ cellular arenas of research including cloning and mitochondrial exchange, with cutting edge high impact papers published every year. “ Fearless and one of the premier innovators in the field”.
Ted Harada (posthumous). Ted has been one of the most prominent patients participating in a stem cell scientific trial ever. He fought for patients and attempts such as right to try every step along the way, and introduced people together in the field. You can see his obituary and tributes here.
Theresa Liao. Powerful advocate for the use of stem cells to treat recessive dystrophic epidermolysis bullosa (RDEB). Through relentless advocacy she has made an outstanding difference in this area of clinical research. “ The parent and visionary patient advocate. ”